50 Shades of Subconjunctival MIGS: Interventional Glaucoma, The Who, What, Why, and How

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from Allergan and Santen Pharmaceuticals.
    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
    Activity Expiration Date: February 29, 2020

    50 Shades of Subconjunctival MIGS: Interventional Glaucoma, The Who, What, Why, and How

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    Description

    Enjoy this 60-minute CME activity in which a panel of experts discuss subconjuctival MIGS. Topics include interventional glaucoma for the subconjuctival MIGS patient, a patient selection case study debate and discussion, and MIGS from the cataract surgeon perspective.

    CME Information

    This activity is supported by educational grants from Allergan and Santen Pharmaceuticals.

    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.

    Activity Expiration Date: February 29, 2020

    Faculty: Ike K. Ahmed, MD; Sahar Bedroot, MD, PhD, Jonathan Myers, MD, Deborah Gess Ristvedt, DO, Arsham Sheybani, MD

    Learning Objectives

    Ophthalmologists who attend this course will:

    • Determine how best to apply therapeutic options and treatment decisions in cases of advanced or refractory glaucoma
    • Identify patient selection criteria and intra- and postoperative steps necessary to optimize outcomes with subconjunctival MIGS